Last updated on April 19, 2014 at 13:20 EDT

Latest PharmaScience Stories

2012-12-11 08:26:54

MONTREAL, Dec. 11, 2012 /PRNewswire/ - Pharmascience Inc. today announced that it has regained global rights to AEG40826, a best-in-class Phase 1b-ready injectable IAP (inhibitor of apoptosis) inhibitor along with all back-up and follow-on compounds, including multiple orally-bioavailable IAP inhibitors, as part of an agreed-upon termination of its oncology collaboration with Human Genome Sciences (HGS), which was acquired by GlaxoSmithKline in July 2012. During the collaboration,...

2012-09-25 06:27:05

Shipment from Health Partners International of Canada will save lives of people affected by disease which has struck nearly 20,000 MONTREAL, Sept. 25, 2012 /CNW/ - A large donation of a vitally needed treatment for cholera is on its way from the Montreal pharmaceutical company Pharmascience Inc. to the African country of Sierra Leone to treat people there who have been stricken by cholera in a serious outbreak of the disease which started earlier this year. The donation has been...